With the European Union Buying Doses, Novavax Has Plenty of Upside Left
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Novavax secured a supply agreement with the European Union, which is a sign of confidence for its vaccine. NVAX stock could move higher from here.
The post With the European Union Buying Doses, Novavax Has Plenty of Upside Left appeared first on InvestorPlace.
More From InvestorPlace